Cardiovascular Diseases (CVD) Clinical Trials

18 recruiting

Cardiovascular Diseases (CVD) Trials at a Glance

18 actively recruiting trials for cardiovascular diseases (cvd) are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Shanghai, Fuzhou, and Almaty. Lead sponsors running cardiovascular diseases (cvd) studies include Children's Hospital Medical Center, Cincinnati, First Affiliated Hospital of Fujian Medical University, and Asfendiyarov Kazakh National Medical University.

Browse cardiovascular diseases (cvd) trials by phase

Treatments under study

About Cardiovascular Diseases (CVD) Clinical Trials

Looking for clinical trials for Cardiovascular Diseases (CVD)? There are currently 18 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiovascular Diseases (CVD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiovascular Diseases (CVD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting

Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study

Cardiovascular Diseases (CVD)Cerebro Vascular Disease
Samsung Medical Center800,000 enrolled1 locationNCT07393412
Recruiting

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

Chronic Kidney DiseaseMetabolic DiseasesCardiovascular Diseases (CVD)
First Affiliated Hospital of Fujian Medical University8,000 enrolled1 locationNCT07547098
Recruiting

Heart Institute BioRepository (HIBR) for Pediatric Heart Disease

Cardiovascular Diseases (CVD)
Children's Hospital Medical Center, Cincinnati5,000 enrolled1 locationNCT07478354
Recruiting

Assessment and Prediction of Cardiovascular Health and Disease Risk Using Wearable Biometrics.

Cardiovascular Disease PreventionCoronary Artery Disease (CAD)Cardiovascular Diseases (CVD)+1 more
University College Dublin100 enrolled1 locationNCT07401550
Recruiting

Study Protocol: 10-Year Follow-Up of Patients Screened for Cardiovascular Risk by the "All With Heart" Association - Development of a Morocco-Specific Risk Score

Cardiovascular Diseases (CVD)
Moroccan Society of Cardiology10,000 enrolled2 locationsNCT07294937
Recruiting
Not Applicable

Ambient Air and Noise Effect on Cardiovascular Health Risk and Lifestyle Intervention to Attenuate It (METSGREEN)

Metabolic SyndromeEnvironmental ExposureCardiovascular Diseases (CVD)+2 more
Regina Grazuleviciene180 enrolled2 locationsNCT07111208
Recruiting

The HELlenic Thoracic Society Initiative for CΟPD and CVD

Chronic Obstructive Pulmonary Disease (COPD)Cardiovascular Diseases (CVD)
Hellenic Thoracic Society900 enrolled2 locationsNCT06595784
Recruiting

Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens

Obesity and OverweightMetabolic SyndromeHypertension+6 more
Shanghai Changzheng Hospital4,094 enrolled1 locationNCT07043166
Recruiting
Not Applicable

Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk

StressBlood PressureCardiovascular Diseases (CVD)
University of Alabama at Birmingham48 enrolled1 locationNCT06811896
Recruiting

A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography

Artificial Intelligence (AI)Cardiovascular Diseases (CVD)Echocardiography+1 more
First Hospital of China Medical University1,600 enrolled37 locationsNCT07133516
Recruiting

Swiss Secondary Prevention and Rehabilitation Registry

Cardiovascular Diseases (CVD)
University Hospital, Basel, Switzerland4,000 enrolled1 locationNCT05500859
Recruiting

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Chronic Kidney DiseasesType 2 DiabetesObesity (Disorder)+2 more
Asfendiyarov Kazakh National Medical University6,720 enrolled1 locationNCT06953180
Recruiting

Clinical Research on 68Ga-FAPI PET/CMR in Cardiovascular Diseases

Cardiovascular Diseases (CVD)
Shanghai East Hospital40 enrolled1 locationNCT07063043
Recruiting
Not Applicable

Effect of Exercise on Tapering Antipsychotics in Patients With Psycho-cardiological Disease(EXTRA-study)

Cardiovascular Diseases (CVD)Depression Anxiety Disorder
Guangdong Provincial People's Hospital106 enrolled1 locationNCT07025590
Recruiting
Phase 1Phase 2

Roxadustat's Effect on Heart, Nutrition, and Inflammation in Hemodialysis Patients

Cardiovascular Diseases (CVD)Kidney Failure, ChronicMalnutrition-Inflammation Syndrome+1 more
Mansoura University46 enrolled1 locationNCT06903559
Recruiting
Not Applicable

Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

HypertensionInflammationCardiovascular Diseases (CVD)
Universidade Federal Fluminense34 enrolled1 locationNCT06917131
Recruiting
Not Applicable

Protective Effect of Sivelestat Against Negative Pulmonary Function and Organ Dysfunction After Cardiovascular Surgery (PANDA VI)

Systemic Inflammatory Response SyndromeAortic DissectionCardiovascular Diseases (CVD)
Nanjing Medical University500 enrolled2 locationsNCT06195267
Recruiting
Not Applicable

Healthy Living With Online suPport & Education for Cardiovascular Disease in the Primary Care Setting

Cardiovascular Diseases (CVD)
Nanyang Technological University1,500 enrolled1 locationNCT06099353